Glen Eagle Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History
Glen Eagle Advisors, LLC
- $603 Billion
- Q4 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 160 shares of TEVA stock, worth $2,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160
Previous 160
-0.0%
Holding current value
$2,129
Previous $2.88 Million
22.3%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TEVA
# of Institutions
676Shares Held
584MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$572 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$519 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$488 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$378 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$362 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $14.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...